We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 63.00 | 61.00 | 65.00 | 63.00 | 63.00 | 63.00 | 15,981 | 08:00:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.80 | 14.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/7/2020 08:30 | Back in at 9:72, this stocks got plenty of upside. | rk23 | |
29/7/2020 08:13 | As I said only pre clinical data. Anyone buying off the back of that was stupid and careless.Now get yourselves into HEMO, a proper company with multiple plays and working on COVID, cancer and blood diseases and lupus. Agreements with ORGS, J&J and $150bn Eli Lilly and awaiting a licensing agreement ? multi bagger | justaman | |
28/7/2020 14:58 | Interesting. Don't discount early stage vaccine candidates if they already have safety profile they could still be used alongside or as carriers for other vaccines ? Am I reading this right ? | the stigologist | |
28/7/2020 14:19 | Definitely one to sharvavitnan shipurily on. | ihussain88 | |
28/7/2020 14:05 | Mate get out of here with your birdies, I've seen you ramp this share on so many boards lol anything with substance, doesnt need ramping! Hold your nerve if you're trading it you'll get a chance to sell in the 20p+ range in the very near future imho. Dyor. | bowssbyjuhelm | |
28/7/2020 13:27 | A little birdie tells me you could be right. Gl | sharif1987 | |
28/7/2020 12:34 | Quite easy who to trust. Just go back and look at the only people who were posting here when we were 2p or 5p | the stigologist | |
28/7/2020 12:31 | After a 100%+ up day a red day is very normal. Nothing to stress over. The potential is nothing short of ridiculous. I still highly believe it will close on the blue side of things. Dyor and hold your nerve if you are traders. Gl | bowssbyjuhelm | |
28/7/2020 12:06 | Yeap been around for the journey with this oneThat was my point, ignore STIG known ramperThis stick will settle and move upwards, has a number of other updates awaited | rk23 | |
28/7/2020 12:04 | People were ramping 30p..my lord! If it holds at 10 to 11...thats good enough for next leg up after news...who remembers when it went to 0.75 and whoosh back to 15p! If only we could grab those once in a while | matunde24 | |
28/7/2020 10:53 | I agree as the highest priced paid was 18p early doors and this hasn't been a sell off only down to profits taken from pi's who cashed in from 8p-10p thereabouts.Holding well at this range just needs a little buying pressure and we could be off at the races | catchingmice | |
28/7/2020 10:35 | Buying as many as I can at this level | computercoders | |
28/7/2020 10:29 | Order book looking strong here like it's about to breakout. GLA | computercoders | |
28/7/2020 10:23 | We may start to move up very soon imo. Lots of profit takers out the way now. Dyor gla | bowssbyjuhelm | |
28/7/2020 10:15 | DNL =3x Approvals expected during next 2 months including an Orphan Drug with FDA decision on September 29 = CHEAPEST UK Biotech a potential 500%++ GEM Diurnal Group (DNL) = MCap £38 M / Cash £15 M or enough untill early 2022 / LOTS of BIG milestones on the way = Still the MOST attractive and CHEAPEST pharma stock in UK has potential to run toward 200p very fast especially on approval of Alkindi in USA (expected in September) and Chronocort in Europe (expected in Q1 ) =STRONG BUY AGGRESSIVE a sleeping giant here .GL Market Cap £38 million Cash £15 million Price 30p Alkindi approval in Australia expected this Quarter Alkindi approval in Israel expected this Quarter FDA decision for Alkindi on September 29 EMA Decision for Chronocort expected in early Q1 2021 | ih_752952 | |
28/7/2020 10:09 | There is a hurdle to clear above 15 p which it did up to 17 p but dropped back on profit taking. Once it has steadied above 15 p you can see that 20 p is the next target. There will be blue sky after that. | kingston78 | |
28/7/2020 09:38 | Defo a blue day imho. Just how blue thats the question loll | bowssbyjuhelm | |
28/7/2020 09:37 | Picked up a few after looking at the financials and yesterdays RNS. This is a very low share price atm. Sp should be between 20p-25p at the lowest. | sharif1987 | |
28/7/2020 09:34 | Slow climb back up by the looks of it so maybe a Blue day later let's see how it goes | catchingmice | |
28/7/2020 09:01 | Good luck i got in at 15p yesterday and thought we would see 20p early doors Will hold for a while not got much in here but nothing else going on at the moment.CTEA looks another good topping up point where it is now | catchingmice | |
28/7/2020 08:50 | I'm in at 12.3 see what happens | computercoders | |
28/7/2020 08:49 | I've proven you don't need to waste time getting to know things, I only started trading a few months ago 'cos of lockdown, up 1,800% so far. So I'm good with it!! | jusjusjus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions